Home Combat Arthritis Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Nov 21, 2020 comments off

Eli Lilly arthritis drug wins emergency approval for COVID-19 use

Arthritis drug baricitinib is authorised for emergency use in combination remdesivir to treat COVID-19 patients.

Read More…

You May Also Like

UPDATE 1-U.S. Supreme Court snubs Novartis appeal over arthritis drug Enbrel – Reuters

Palace Insiders Are Upset Over Prince Harry Saying His Dad Passed on a "Cycle" of “Genetic Pain" – Yahoo Canada Shine On

India's Cipla says supply of COVID-19 drug remdesivir catching up with demand – Reuters

All gas, no brakes: Testosterone may act as 'brake pedal' on immune response

Fallout From The 2021 Kentucky Derby – Standardbred Canada

AbbVie faces the biggest challenge yet to its best-selling medicine, Humira, as an unlikely Icelandic drugmaker launches a legal fight over 'outrageous' patents